NeoGenomics's market cap is currently ―. The company's EPS TTM is $-0.701; its P/E ratio is -19.63; NeoGenomics is scheduled to report earnings on April 30, 2024, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 155.55M	$ 151.95M	$ 146.92M	-	$ 138.71M
Gross Profit	$ 67.59M	$ 62.31M	$ 59.89M	$ -82.41M	$ 56.83M
EBIT	$ -1.55M	$ -24.29M	$ -29.16M	$ -35.19M	$ -26.38M
EBITDA	$ 17.54M	$ -5.44M	$ -10.19M	$ -16.64M	$ -7.60M
Net Income Common Stockholders	$ -14.33M	$ -18.52M	$ -24.33M	$ -30.80M	$ -22.69M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 415.20M	$ 402.26M	$ 409.35M	$ 275.61M	$ 263.18M
Total Assets	$ 1.68B	$ 1.68B	$ 1.70B	$ 1.71B	$ 1.74B
Total Debt	$ 611.68M	$ 605.70M	$ 609.59M	$ 752.63M	$ 785.74M
Net Debt	$ 196.48M	$ 203.44M	$ 200.24M	$ 477.02M	$ 522.56M
Total Liabilities	$ 739.69M	$ 730.81M	$ 738.92M	$ 734.71M	$ 742.01M
Stockholders Equity	$ 941.54M	$ 947.43M	$ 956.19M	$ 974.46M	$ 998.02M
Cash Flow	-
Free Cash Flow	$ 10.73M	$ -9.77M	$ -9.04M	$ -22.62M	$ -8.22M
Operating Cash Flow	$ 17.78M	$ -5.50M	$ -1.55M	$ -12.69M	$ -3.69M
Investing Cash Flow	$ 17.20M	$ 20.82M	$ 14.95M	$ 23.74M	$ -1.06M
Financing Cash Flow	$ 1.27M	$ 1.84M	$ 64.00K	$ 1.38M	$ 1.80M

Currency in USD

NeoGenomics Earnings and Revenue History

Income Statement >

NeoGenomics Debt to Assets

Balance Sheet >

NeoGenomics Cash Flow

Cash Flow >

NeoGenomics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing